Research progress of antioxidant drugs in myocardial ischemia-reperfusion injury / 药学学报
Acta Pharmaceutica Sinica
;
(12): 1845-1855, 2021.
Artículo
en Chino
| WPRIM
| ID: wpr-887001
ABSTRACT
Myocardial ischemia-reperfusion injury (MIRI) is one of the most difficulties in the studies of cardiovascular diseases, and excessive reactive oxygen species (ROS) accumulation in cells is the main cause of it. Reducing ROS level by antioxidant drugs to protect cardiomyocytes is being the spotlight on MIRI treatment. In this review, the research progress of antioxidant drugs in myocardial ischemia-reperfusion injury in recent years was summarized.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Acta Pharmaceutica Sinica
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS